Table 43.
Prevalence of resistance to selected antimicrobials in Campylobacter jejuni from broilers, using harmonised ECOFFs, 26 EU/EEA MSs, 2016
| Country | GEN | STR | CIP | NAL | ERY | TET | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prev. | 95% CI | Prev. | 95% CI | Prev. | 95% CI | Prev. | 95% CI | Prev. | 95% CI | Prev. | 95% CI | |
| Austria | 0 | 0–0.7 | 3 | 1.1–4 | 36.5 | 32.2–40.9 | 34.3 | 30–38.6 | 0 | 0–0.7 | 23.5 | 19.7–27.4 |
| Belgium | 0 | 0–1.6 | 0.5 | 0–2.4 | 40.7 | 34.3–47.3 | 38.1 | 31.8–44.7 | 0 | 0–1.6 | 31.2 | 25.3–37.6 |
| Bulgaria | 0 | 0–0.8 | 2.6 | 0.6–3.2 | 17.8 | 14.4–21.8 | 17.8 | 14.4–21.8 | 2.3 | 0.5–2.9 | 9.1 | 6.5–12.1 |
| Croatia | 0 | 0–0.3 | 2 | 0.1–0.9 | 32.4 | 29.8–35.2 | 26.9 | 24.4–29.5 | 0 | 0–0.3 | 19 | 16.8–21.4 |
| Cyprus | 0.5 | 0–1.8 | 8.1 | 3–8.4 | 36.9 | 31.5–42.7 | 32.3 | 27.1–37.9 | 0 | 0–1.2 | 36.3 | 31.5–42.7 |
| Czech Republic | 0 | 0–1.5 | 0 | 0–1.5 | 19 | 14.2–24.6 | 18.6 | 13.8–24.1 | 0 | 0–1.5 | 8.9 | 5.6–13.2 |
| Denmark | 0 | 0–0.5 | 0.8 | 0.3–1.8 | 4.9 | 3.5–6.7 | 4.5 | 3.1–6.2 | 0.1 | 0–0.8 | 2.9 | 1.8–4.3 |
| Finland | 0 | 0–0.2 | 0.1 | 0–0.3 | 0.4 | 0.1–0.7 | 0.6 | 0.3–1.1 | 0 | 0–0.2 | 0.3 | 0.1–0.6 |
| Germany | 0.2 | 0–1.2 | 1.3 | 0.5–2.9 | 25.4 | 22.6–31 | 24.1 | 21.4–29.6 | 0 | 0–0.8 | 17.9 | 15.3–22.8 |
| Greece | 0 | 0–0.9 | 2.6 | 1.2–4.7 | 29.6 | 25.1–34.5 | 25.3 | 21–29.9 | 0 | 0–0.9 | 24.5 | 20.3–29.1 |
| Hungary | 0 | 0–0.8 | 0.9 | 0.2–2.3 | 35 | 30.3–39.4 | 33.6 | 29–38 | 0 | 0–0.8 | 20.2 | 16.5–24.1 |
| Ireland | 0 | 0–1.4 | 1.1 | 0.2–3.4 | 16.5 | 12.5–22.1 | 16.5 | 12.5–22.1 | 0 | 0–1.4 | 16.9 | 12.9–22.5 |
| Italy | 0 | 0–0.5 | 0.3 | 0–0.9 | 26.3 | 23.3–29.5 | 21 | 18.2–23.9 | 2.6 | 1.6–4 | 23.1 | 20.2–26.1 |
| Latvia | 0 | 0–3.6 | 20 | 12.7–29.2 | 47 | 36.9–57.2 | 46 | 36–56.3 | 0 | 0–3.6 | 31 | 22.1–41 |
| Lithuania | 0 | 0–0.9 | 1.8 | 0.4–2.7 | 27.9 | 23.8–32.5 | 27.9 | 23.8–32.5 | 0 | 0–0.9 | 18.1 | 14.6–22.1 |
| Poland | 0 | 0–2.1 | 30.2 | 24.7–39.1 | 91.6 | 86.6–95.5 | 83.7 | 81.8–92.2 | 0 | 0–2.1 | 70.3 | 66.4–80.1 |
| Portugal | 0 | 0–2.3 | 0.6 | 0–3.4 | 39.7 | 32.1–47.8 | 36.7 | 29.2–44.6 | 4.3 | 1.8–8.8 | 34.2 | 26.9–42 |
| Romania | 0 | 0–0.4 | 2.1 | 1.1–3.1 | 29 | 23.6–29.7 | 27.9 | 22.7–28.7 | 0.1 | 0–0.7 | 18.2 | 14.2–19.4 |
| Slovakia | 0.4 | 0–1.3 | 4.7 | 1.6–5.1 | 24.4 | 20.5–28.8 | 17.5 | 8.4–14.6 | 1.5 | 0.3–2.4 | 13.5 | 10.4–17.1 |
| Slovenia | 0 | 0–1.8 | 0 | 0–1.8 | 35.1 | 28.9–42 | 29.2 | 16.5–28.5 | 0 | 0–1.8 | 24.5 | 13.4–24.7 |
| Spain | 0 | 0–0.7 | 1.2 | 0.4–2.6 | 28.8 | 24.9–33 | 28.6 | 24.7–32.8 | 0.2 | 0–1.1 | 26.6 | 22.8–30.7 |
| Sweden | 0 | 0–0.1 | 0.1 | 0–0.1 | 1.9 | 1.5–2.3 | 1.9 | 1.5–2.9 | 0 | 0–0.1 | 2.3 | 1.9–2.8 |
| United Kingdom | 0 | 0–0.7 | 0.6 | 0–1.5 | 21.8 | 18.1–25.6 | 22.1 | 18.5–26 | 0.3 | 0–1.1 | 30.2 | 26.2–34.5 |
| Total (23MSs) | 0.03 | 0.01–0.07 | 1.7 | 1.5–1.9 | 18.4 | 17.8–19 | 17 | 16.4–17.6 | 0.37 | 0.28–0.48 | 14 | 13.4–14.5 |
| Iceland | 0 | 0–0.5 | 0 | 0–0.5 | 0.4 | 0–1 | 0.4 | 0–1 | 0 | 0–0.5 | 0.2 | 0–0.8 |
| Norway | 0 | 0–1.9 | 2.1 | 0.6–5.4 | 6.4 | 3.3–10.9 | 6.4 | 3.3–10.9 | 0 | 0–1.9 | 3.2 | 1.2–6.8 |
| Switzerland | 0.4 | 0–1.4 | 2 | 1–3.7 | 14.5 | 11.5–17.9 | 14.5 | 11.5–17.9 | 0.8 | 0.2–2.1 | 11.3 | 8.6–14.4 |
ECOFFs: epidemiological cut‐off values; MSs: Member States; N: number of isolates tested; Prev.: percentage of slaughtered broilers (caecal samples) harbouring resistant isolates per category of susceptibility; 95% CI: 95% confidence interval of % Prev.; CIP: ciprofloxacin; ERY: erythromycin; GEN: gentamicin; NAL: nalidixic acid; STR: streptomycin; TET: tetracycline.